Types of Cancer > Gynecologic Cancers > Cervical Cancer > News
![]()
November 2009
New guidelines call for first cervical cancer screen at 21; less frequent Pap tests
October 2009
Liquid-based cytology not better than Pap test at detecting cervical neoplasia
Cervical cancer prevention approaches not infallible
July 2009
HIV-infected women often neglect cervical cancer screening
Cervical screening has little impact on cancer rates in young women
June 2009
HPV testing does not improve cervical cancer screening
Resection of uterovaginal compartment improves cervical cancer control
May 2009
Risk of cervical cancer elevated for decades after treatment for CIN
Topotecan-docetaxel combo beneficial in heavily treated gynecologic cancer patients
April 2009
SNPs sharpen absolute risk estimates for prostate cancer
HPV screening reduces cervical cancer deaths in rural India
March 2009
Inflammatory bowel disease not linked to cervical abnormalities
Cervical cancer outcomes differ according to HPV genotype
January 2009
HPV test, then Pap test, then repeat HPV test may improve cervical cancer detection
Nearly half of grade 2 cervical intraepithelial neoplasias will regress
December 2008
Cervical cancer chemotherapy better tolerated by black women than white women
October 2008
Hysterectomy for cervical cancer feasible in obese women
Cetrorelix offers practical benefits in prep for transcervical resection of endometrium
September 2008
Overexpression of p16 increases specificity of HPV testing for cervical cancer
August 2008
DNA methylation markers help screen for cervical cancer
June 2008
Small cell cervical cancer usually has poor prognosis
May 2008
HPV test better long-term predictor of cervical lesions than cytology
April 2008
Delayed screening main cause of advanced cervical cancer
March 2008
HPV testing more sensitive than cytology when screening for cervical neoplasia
November 2007
Post-therapy PET imaging predicts outcome in cervical cancer
Early invasive cervical cancer imaging better with MRI than CT
October 2007
HPV testing more sensitive than Pap screening for detecting cervical neoplasia
August 2007
Globally, cervical cancer most often due to vaccine-susceptible HPV 16/18
Good outcomes with conservative management of stage IB1 cervical cancer
July 2007
New ELISA test may improve screening for cervical cancer
June 2007
Laparoscopic hysterectomy may be best operation for early cervical cancer
Bivalent vaccine prevents HPV-related cervical lesions
Lower limb lymphedema common in survivors of gynecological cancer
May 2007
Laparoscopic hysterectomy effective in cervical cancer
April 2007
Cervical abnormalities prevalent among HIV-infected adolescent girls
Self-sample HPV kit may boost cervical cancer screening rates
One-visit screening for cervical cancer may be feasible in developing countries
March 2007
Merck says CDC endorses cervical cancer vaccine
Supracervical hysterectomy alternative for ovarian cancer
February 2007
Easier cisplatin regimen for advanced cervical cancer appears less effective
Absolute risk of second cancer small after hairy cell leukemia
December 2006
Smoking multiplies HPV-16-related cervical cancer risk
November 2006
HPV linked to recurrence of high-grade cervical intraepithelial neoplasia
HPV and smoking synergistic in raising cervical cancer risk
Uptake of cervical cancer screening seen to be main factor in effectiveness
HPV test may excel over Pap smears for predicting cervical cancer
CDC to subsidize Merck's cervical cancer vaccine
October 2006
Inosiplex may be useful for treatment-resistant cervical condylomata
EU urged to vaccinate girls against cervical cancer
August 2006
HIV drug also inhibits HPV in vitro, points to cervical cancer prevention
More cervical biopsies improve sensitivity of colposcopy
July 2006
HPV load may help determine cervical cancer risk
June 2006
WellPoint to reimburse for cervical cancer vaccine
Radical vaginal trachelectomy may preserve fertility in cervical cancer patients
US FDA approves Hycamtin for cervical cancer
May 2006
Cervical cancer screening with reflex HPV testing seen cost-effective
FDA panel backs Merck cervical cancer vaccine
April 2006
HPV testing supported as sole primary screening test for cervical cancer
HPV vaccine provides sustained protection against cervical lesions
Smoking increases risk of squamous cell cervical cancer
February 2006
Surgery by gynecologic oncologist improves ovarian cancer survival
January 2006
Gynecologic oncologists have better outcomes than surgeons treating ovarian cancer
HIV infection linked to increased risks of high-grade cervical lesions
Surgery reduces gynecologic cancer risk in Lynch syndrome patients
Superiority of liquid-based cytology for cervical screening questioned
December 2005
Contraceptive use, pregnancy, and parity unrelated to risk of cervical neoplasia
Vaccine highly effective in preventing cervical cancer-associated HPV infections
Fluorouracil inferior to cisplatin in cervical cancer
November 2005
"Screen and treat" strategies reduce risk of cervical cancer
October 2005
Cervical cancer vaccine prevents lesions
September 2005
Host factor role confirmed in etiology of squamous cell cervical cancer
August 2005
Triple modality approach effective against cervical cancer
Optical coherence tomography seen feasible for cervical screening
July 2005
Absorbable sling enhances early continence after radical prostatectomy
High-grade cervical lesions progress in adolescents at similar rate as in adults
June 2005
HPV test affordable adjunct to cervical cancer screening
Gates backs cervical cancer vaccines for poor
Sexual functioning similar after total or supracervical hysterectomy
May 2005
Failure to get a Pap test often to blame for cervical cancer diagnosis
April 2005
Variations in killer immunoglobulin-like receptor gene influence cervical cancer risk
January 2005
Few older cervical carcinoma patients get aggressive treatment
Wider HPV testing may not spot more cervical cancers
Passive smoking linked to cervical cancer
December 2004
Cervical cancer an "epidemic" in poor countries
Smaller centers may provide suboptimal cervical cancer care
November 2004
Ireland urged to adopt cervical screening program
Colposcopy unwarranted in young women with low-grade cervical lesions
October 2004
Cyclophosphamide for lupus may increase cervical neoplasia risk
September 2004
Teenage girls urged to visit gynecologist before Pap testing begins
Zoledronic acid impedes development of cervical cancer in mice
August 2004
Multivalent HPV vaccine could prevent most cervical cancers
July 2004
Socioeconomic disparities persist in cervical cancer diagnosis and mortality
Antiretroviral therapy fosters regression of cervical lesions in HIV-infected women
UK cervical cancer screening "saves 5,000 lives a year"
May 2004
Glaxo launches huge cervical vaccine trial
April 2004
Triennial cervical cancer screening with cytology and HPV DNA testing cost-effective
Cadherin methylation may provide prognostic marker for cervical cancer
March 2004
Invasive cervical squamous cell carcinoma rates declines in U.S. women
Abbreviated surveillance safe after treatment of high-grade cervical dysplasia
February 2004
HPV testing helps stratify cervical cancer risk when Pap smear is equivocal
January 2004
"Absolute survival benefit" best conveys risk and benefits of chemotherapy
December 2003
Neoadjuvant chemotherapy timing crucial in cervical cancer
Cervical cancer a potential long-term sequela of chlamydial infection
Serum HPV DNA linked to advanced cervical cancer
Women distrust risk-based cervical cancer screening
HPV-based approach to cervical cancer screening could improve detection rates
Elderly women seen as over-screened for breast, cervical cancers in U.S.
November 2003
Radical hysterectomy for early cervical cancer tied to lasting sexual problems
Cervical cancer risk remains high over time after detection of HPV
October 2003
UK rolls out liquid based cytology for cervical cancer
Findings support less frequent cervical cancer screening in low-risk women
September 2003
Outcomes similar for total and supracervical hysterectomy
August 2003
Persistently high HPV load predicts precancerous cervical lesions
UK invites tenders for liquid-based cytology cervical screening
Visual cervical cancer screening appropriate in developing countries
HIV infection increases risk of cervical cancer in African women
HPV urine testing may be option when cervical exam not feasible
Combining HPV vaccination with cervical cancer screening may be cost effective
Inadequate cervical smears linked to increase risk of subsequent cancer
Women unaware of viral link to cervical cancer
July 2003
Obesity may double risk of cervical adenocarcinoma
Gynecologic surgery may protect BRCA carriers against ovarian cancer
Hyperthermia improves survival with locally advanced cervical carcinoma
Allelic imbalance tied to telomerase activity in cervical lesions
Lower social class linked to higher risk of cervical cancer
Cervical screening intervals should vary for different age groups
June 2003
Reflex HPV testing identifies most women with high-grade cervical lesions
May 2003
Cytology not reliable in predicting cervical lesion progression in HIV-infected women
Endometrial cancer can develop after radiation for cervical carcinoma
April 2003
Most cases of cervical dysplasia do not progress to cancer
Review confirms link between oral contraceptive use and cervical cancer
Screening plus vaccines could stop cervical cancer in Germany
February 2003
HPV viral load may identify cervical neoplasia risk
Risk of cervical cancer associated with 30 HPV types classified
January 2003
Childbearing possible following modified surgery for invasive cervical cancer
Novel oral vaccine may be useful therapy for cervical cancer
Risk of invasive cancer increases with longer cervical screening intervals
December 2002
Longer cervical screening interval may be suitable when Pap/HPV tests negative
Stiff ectocervical brush biopsy accurate, less traumatic than cervical punch biopsy
November 2002
Cervical cancer incidence remains high among Hispanic women in US
Vaccine prevents HPV infection and related cervical neoplasia
American Cancer Society issues new guidelines for cervical cancer screening
October 2002
HPV infection linked to oncogene amplifications in cervical tumors
HPV DNA screening may improve cervical abnormality detection
C. trachomatis infection tied to risk of cervical cancer
Cervical cancer screening can be cost-effective in developing countries
September 2002
Smoking associated with increased cervical cancer risk in women with HPV
Type-specific persistence of HPV a risk factor for high-grade cervical lesions
August 2002
HPV58 variants linked to cervical cancer in Hong Kong
A single HLA allele sufficient to confer protection against cervical neoplasia
July 2002
Infection with HPV type 16 linked to high risk of cervical neoplasia and cancer
Public funding of Pap tests linked to lower rate of invasive cervical cancer
May 2002
Combined approach most cost-effective cervical cancer screening method
Low-grade cervical dysplasia usually reverts to normal in young girls
April 2002
Revised guidelines on cervical cytology issued
Circumcision reduces risk of penile HPV infection, cervical cancer in partners
Gynecologic abnormalities common among women with rectal cancer
Cervical cancer risk factors associated with higher Pap test use
March 2002
Oral contraceptives raise cervical cancer risk in HPV-infected women
FDA advisors back new screening method for cervical cancer
February 2002
Dual agents make sentinel node identification reliable in cervical cancer patients
December 2001
LMW heparin or compression both prevent thromboembolism after gynecologic surgery
IL-10-promoter polymorphism linked to cervical cancer risk
Cervical and lung cancers are frequent and aggressive in women with HIV
November 2001
Lethality of cervical cancer higher in older women due to neglected screening
Modified smallpox vaccine to be tested as cervical cancer treatment
Fertility may be preserved for some cervical cancer patients
October 2001
Cervical cancer unchecked in poor countries
Canadian regulatory authorities clear TriPath automated cervical cancer test
September 2001
HPV infection, cervical disease prevalent in HIV-infected women on HAART
Combined chemoradiation therapy improves outcomes in cervical cancer
Aggressive HPV variant common among Mexican women with cervical cancer
HPV testing plus cervical cancer screen is cost effective in HIV-infected women
August 2001
Multiple HPV types present in women with cervical dysplasia
DNA alterations better marker of cervical dysplasia than HPV
July 2001
New surgical procedure for selected cervical cancer patients preserves fertility
Computer-based screening of cervical smears reduces excess interventions
Minilaparotomy is a feasible approach for colon cancer resection
May 2001
Cervical cancer as AIDS-defining illness still on the rise
HIV-related immunosuppression may contribute to cervical dysplasia
New device collects cervical cells in a single step
April 2001
Key cofactors involved in HPV-associated cervical cancer identified
HPV-18 detection in early-stage cervical carcinoma predicts poor outcome
January 2001
CDC stratifies cervical cancer rates by race, ethnicity for first time
October 2000
Mitomycin C as adjunct to radiotherapy shows promise in advanced cervical cancer
September 2000
Incidence of cervical adenocarcinoma subtypes shifting in Norwegian women
Two-stage screening for cervical cancer expands access when resources limited
August 2000
Tumor growth rate, not delayed presentation, determine cervical cancer stage
Cervical carcinoma can metastasize to myocardium
July 2000
Helix begins cervical cancer research with Althea Foundation
June 2000
Routine cervical screening recommended for lesbians
Normal colposcopy after low-grade cervical smear usually indicates benign prognosis
Cervical cancer risk in HIV-infected women explained by HPV persistence
Chronic stress may increase risk of high-grade cervical neoplasia
Senate committee approves breast and cervical cancer bill
Pap smears should remain the primary method of cervical cancer screening
Fluorescence spectroscopy helps diagnose cervical intraepithelial neoplasia
Postpartum diagnosis of cervical cancer associated with poor outcome
Tobacco may be a key to therapeutic vaccine for cervical cancer
May 2000
More specific screening tests for cervical cancer needed
Endocervical curettage aids evaluation of women with abnormal Pap smears
House approves breast and cervical cancer treatment bill
Anal cancer risk increased in husbands of women with cervical cancer
Cisplatin-based therapy improves survival of patients with high-risk, early-stage cervical cancer
April 2000
Virus bearing papillomavirus E2 gene slows cervical cancer growth, increases life expectancy in mice
Radical surgery preserves fertility in some cervical cancer patients
February 2000
Deep venous thrombosis prophylaxis cost-effective for gynecologic cancer surgery patients
January 2000
Continued high cervical cancer rates in Hong Kong blamed on lack of funding
HPV test better than Pap test for cervical cancer screening in high-risk populations
Chlamydia infection now linked to cervical cancer
December 1999
Radical trachelectomy comparable to radical hysterectomy for Stage 1 cervical cancer
Human papillomavirus 58 linked to favorable cervical cancer outcome
Church-based cervical cancer screening program reaches underserved women
November 1999
Color flow Doppler useful in determining treatment protocols for early cervical cancer
Stage III ovarian cancer survival better in women treated by gynecologic oncologists
October 1999
Mortality rate from cervical cancer affected by race
August 1999
Mutated HPV DNA vaccine protects mice against cervical cancer
July 1999
Senators advocate breast, cervical cancer treatment for uninsured women
Lactose absorption linked to ovarian cancer
Genetic predisposition to cervical cancer identified
June 1999
AutoCyte's PREP approved by FDA for primary cervical cancer screening
Minilaparotomy feasible for outpatient management of ovarian cysts
May 1999
Treatment of cervical cancer may compromise sexual function
April 1999
Computer-assisted primary screening of cervical smears may replace manual screening
British cervical screening program results in fewer cases of invasive disease
March 1999
Trachelectomy may safely preserve fertility in women with cervical cancer
Adjuvant chemo/radiation treatment of cervical cancer improves survival
Bill would fund treatment for breast, cervical cancer
Cervical cancer screening less common in women with learning disorders
February 1999
Chemotherapy plus radiation improves survival in patients with invasive cervical cancer
Conservative management effective for stage 1A1 cervical adenocarcinoma
Selective screening for women at high risk of cervical cancer saves money
Mild, moderate cervical dysplasias more likely to regress than progress
Most health authorities in England achieve cervical screening target
January 1999
HPV DNA test predicts cervical neoplasia in women with abnormal Pap test





